160 related articles for article (PubMed ID: 1987452)
21. Characteristics of high affinity and low affinity adenosine binding sites in human cerebral cortex.
John D; Fox IH
Adv Exp Med Biol; 1986; 195 Pt B():57-69. PubMed ID: 2429512
[TBL] [Abstract][Full Text] [Related]
22. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
[TBL] [Abstract][Full Text] [Related]
23. G-protein-coupled A1 adenosine receptors in coated vesicles of mammalian brain: characterization by radioligand binding and photoaffinity labelling.
González-Calero G; Cubero A; Klotz KN
Cell Signal; 1992 Nov; 4(6):737-45. PubMed ID: 1489663
[TBL] [Abstract][Full Text] [Related]
24. Differential development of adenosine A1 and A2b receptors in the rat duodenum.
Peachey JA; Hourani SM; Kitchen I
Br J Pharmacol; 1996 Nov; 119(5):949-58. PubMed ID: 8922745
[TBL] [Abstract][Full Text] [Related]
25. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
Prentice DJ; Hourani SM
Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
[TBL] [Abstract][Full Text] [Related]
26. 2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors.
Klotz KN; Lohse MJ; Schwabe U; Cristalli G; Vittori S; Grifantini M
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):679-83. PubMed ID: 2615857
[TBL] [Abstract][Full Text] [Related]
27. Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.
Ramkumar V; Barrington WW; Jacobson KA; Stiles GL
Mol Pharmacol; 1990 Feb; 37(2):149-56. PubMed ID: 2304450
[TBL] [Abstract][Full Text] [Related]
28. [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors.
Jacobson KA; Ukena D; Kirk KL; Daly JW
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4089-93. PubMed ID: 3012550
[TBL] [Abstract][Full Text] [Related]
29. Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
Jacobson KA; Stiles GL; Ji XD
Mol Pharmacol; 1992 Jul; 42(1):123-33. PubMed ID: 1635550
[TBL] [Abstract][Full Text] [Related]
30. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
Nonaka H; Mori A; Ichimura M; Shindou T; Yanagawa K; Shimada J; Kase H
Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067
[TBL] [Abstract][Full Text] [Related]
31. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
Kirk IP; Richardson PJ
Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
[TBL] [Abstract][Full Text] [Related]
32. Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.
Smith AD; Cheek DJ; Buxton IL; Westfall DP
Clin Exp Pharmacol Physiol; 1997 Jul; 24(7):492-7. PubMed ID: 9248666
[TBL] [Abstract][Full Text] [Related]
33. Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.
Ji XD; Jacobson KA
Drug Des Discov; 1999 Nov; 16(3):217-26. PubMed ID: 10624567
[TBL] [Abstract][Full Text] [Related]
34. Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.
Kim YC; Ji XD; Jacobson KA
J Med Chem; 1996 Oct; 39(21):4142-8. PubMed ID: 8863790
[TBL] [Abstract][Full Text] [Related]
35. Labelling of Ri adenosine receptors in rat fat cell membranes with (-)-[125iodo]N6-hydroxyphenylisopropyladenosine.
Ukena D; Furler R; Lohse MJ; Engel G; Schwabe U
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(3):233-40. PubMed ID: 6089004
[TBL] [Abstract][Full Text] [Related]
36. [3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies.
Fredholm BB; Lindström K; Dionisotti S; Ongini E
J Neurochem; 1998 Mar; 70(3):1210-6. PubMed ID: 9489743
[TBL] [Abstract][Full Text] [Related]
37. A new class of adenosine receptors in brain. Characterization by 2-chloro[3H]adenosine binding.
Chin JH; DeLorenzo RJ
Biochem Pharmacol; 1986 Mar; 35(5):847-56. PubMed ID: 3006693
[TBL] [Abstract][Full Text] [Related]
38. [3H]-8-cyclopentyl-1,3-dipropylxanthine binding to A1 adenosine receptors of intact rat ventricular myocytes.
Martens D; Lohse MJ; Schwabe U
Circ Res; 1988 Sep; 63(3):613-20. PubMed ID: 2842086
[TBL] [Abstract][Full Text] [Related]
39. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA
J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
Mazzoni MR; Buffoni RS; Giusti L; Lucacchini A
J Recept Signal Transduct Res; 1995; 15(7-8):905-29. PubMed ID: 8673723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
